This week, the financing heat in the medical and health field has risen, covering cutting-edge tracks such as tumor immunity, nuclear drugs, brain computer interfaces, and
· National Intellectual Property System Talent Work Conference Held in Beijing · Shenzhen Deploys and Promotes the Comprehensive Pilot Work of the Intellectual Property Finance Ecosystem
On April 13th, Zhejiang Province officially released the first national special guidance on patent layout in the field of biopharmaceuticals, filling the gap in the systematic
This issue’s information covers GPCR biased ligand design, 3D printed biomimetic gas tubes, magnetic resonance panoramic quantitative imaging, novel mechanisms of liver transplant rejection, endogenous analgesic
Nowadays, the pharmaceutical market is mainly divided into two tracks: small molecule chemical drugs and large molecule biopharmaceuticals, which have vastly different molecular structures, production processes,
The healthcare industry is in a period of innovation explosion, with cutting-edge technology rapidly integrating with clinical needs, and high-quality medical assets becoming the core direction
On May 7, the China National Intellectual Property Administration officially released the white paper “Status of China’s Intellectual Property Protection in 2025”, comprehensively reviewed the achievements
Why is the price of high-quality patents much higher than ordinary applications when applying for patents? Many companies only see price figures and cannot see the
Recently, the “2026 Medical and Health Institution Technical Manager Training” was successfully held online, jointly organized by the National Technology Transfer Talent Training Base (Beijing), the
In this issue, eight major achievements of national medicine were selected, and eight core scientific research breakthroughs were disassembled, including neuroblastoma, KRAS mutant solid tumor, fundus